Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort is a research paper published in Radiology (2020). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R01AR056973
NIH HHS
Grant: S10 OD021701
NHLBI NIH HHS
Grant: T32 HL134621
NIH HHS
Grant: S10 OD018224
NIAMS NIH HHS
Grant: R01 AR070101
National Institutes of Health
Grant: 5R01AR056973-14
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
National Institutes of Health
Grant: 5R01AR070101-05
MR Assessment of Bioenergetics and Microvascular Function in Dystrophic Muscle
National Institutes of Health
Grant: 1S10OD021701-01
A Prisma Upgrade for the OHSU Advanced Imaging Research Center 3T MRI Instrument
National Institutes of Health
Grant: 1S10OD018224-01
A High-Performance Computing System for Advanced Imaging
National Institute of Neurological Disorders and Stroke
Influential Citations
3
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 4 of Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
Additional file 4 of Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
Additional file 1 of Utilization of T1-Mapping for the pelvic and thigh muscles in Duchenne Muscular Dystrophy: a quantitative biomarker for disease involvement and correlation with clinical assessments
Additional file 1 of Utilization of T1-Mapping for the pelvic and thigh muscles in Duchenne Muscular Dystrophy: a quantitative biomarker for disease involvement and correlation with clinical assessments